Robot suit aims to keep ALS patients walking longer
NCT ID NCT06199284
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether a robotic exoskeleton called Atalante can safely help people with ALS maintain their ability to walk. The idea is that the suit provides natural leg movements and feedback to the brain, which may slow down walking decline. About 20 adults with slow-progressing ALS will try the device in a supervised setting. The main goal is to check safety, but researchers will also measure walking speed, balance, and breathing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALS (AMYOTROPHIC LATERAL SCLEROSIS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Pitié-Salpêtrière
Paris, 75013, France
-
Institut de myologie
Paris, 75013, France
-
Station Debout
Paris, 75001, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain implant aims to give voice to those trapped in silence
- Nasal spray aims to tame brain inflammation in ALS
- Robotic arm could help people with paralysis regain independence at home
- Experimental cell therapy tested in 3 ALS patients
- Gene therapy injection hopes to slow ALS
- Super-Sharp brain scanner could revolutionize diagnosis of dementia and cancer